GSK3B and non-small cell lung carcinoma: Similarly, the TMED3-mediated activation of AKT/GSK3β/β-catenin axis enhances the expression of c-myc and cyclin D1, thus leading to in vitro NSCLC cell proliferation and in vivo xenograft tumor growth [56].